Published: Mar 23, 2021, 24:45 IST | Updated: Mar 23, 2021, 24:45 IST
In a fresh set back for AstraZeneca, the National Institute of Allergy and Infectious Diseases (NIAID) in the US said that AstraZeneca may have included out-of-date information during trials of its COVID-19 vaccine.